
Juvenile Arthritis
Seconds count when you have arthritis…
What does a second mean to you? For many people a second could mean the difference between missing the last post or running late and not getting the last train home. But for someone with arthritis, those seconds are regularly missed and they can turn from minutes to hours in the struggle to get through the day.
Continue reading
Montmorency cherry juice may reduce joint pain as experts find it lowers uric acid levels and an inflammation biomarker
The Montmorency cherry – a variety of sour cherry – seems to reduce levels of uric acid, which can have an impact on joint pain, says a new small study in the Journal of Functional Foods.
A total of 12 healthy people (average age 26 years old) were split into groups. Half were given 30ml of juice concentrate mixed with 100ml of water (works out as 90 Montmorency cherries). The others were given 60ml of juice concentrate mixed with 100ml of water (works out as 180 Montmorency cherries). Continue reading
Fear of pain could increase risk of multisite pain
Pain catastrophising and fear of pain might increase the risk of developing multisite pain following injury, says research due to be published in The Journal of Pain.
Experts looked at the value of pain catastrophising, fear of pain and depression in the prediction of multisite pain after delayed onset muscle soreness (ie pain induced in the laboratory). A total of 119 (63 women, 56 men) healthy university students took part in the study. Continue reading
New class of anti-arthritis drugs could treat multiple inflammatory diseases
A new class of anti-arthritic drugs reduces both arthritic joint inflammation and periodontitis (gradual loss of bone and tissues that support the teeth) says a study in The American Journal of Pathology.
One of the issues with current drugs is that medication effective for one disorder may exacerbate the other – making it difficult to treat people with more than one inflammatory disease.
The new class of drugs (DTrp) are known as MC receptor agonists. Continue reading
UK reform essential in care of people with arthritis
Widespread reform is needed to enable high quality care planning for people in the UK with long-term conditions, such as arthritis, says a Health Committee report. The settings discussed include home, hospitals and specialist care.
Services for rheumatology patients should be maintained across all settings and cannot simply be moved into the community, according to evidence submitted to the Health Committee by The British Society for Rheumatology. The report reads: Continue reading